Abstract
Summary Based upon studies of the relationships of blocking and binding antibodies to IF in patients with pernicious anemia, it has been hypothesized that the antigenic site on human IF for the blocking antibody may be a more potent immunogen than the corresponding site for binding antibody. The results of this study are in agreement with this hypothesis in that rabbits given a single injection of approximately 270 ng human IF were found to have low concentrations of blocking antibody but no detectable binding antibody in their serum. Rabbits challenged with the same amount of IF complexed to B12 produced both blocking and binding antibodies. The concentration of blocking antibody in the latter animals was significantly higher than in the group immunized with IF, indicating that B12 enhances the immunogenic potencies of both antigenic sites on IF. Binding antibody was detected in both the γM and γG classes of immunoglobulins. Blocking antibody was found to be predominantly γG.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
